DRUG THERAPY FOR ANDROGEN-POSITIVE BREAST CANCER

DRUG THERAPY FOR ANDROGEN-POSITIVE BREAST CANCER

There are some types of breast cancer (BC) that depend on their molecular characteristics. However, lately researchers provide date regarding the presence of additional receptors of triple negative breast cancer (TNBC). One of them is LA R-subtype that has androgen receptors (AR) on breast cancer ce...

Full description

Bibliographic Details
Main Authors:	A. D. Zikiryakhodjhaev, A. A. Fedenko, M. V. Starkova, V. S. Surkova, M. V. Sedova
Format:	Article
Language:	Russian
Published:	Russian Academy of Sciences, Tomsk National Research Medical Center 2021-03-01
Series:	Сибирский онкологический журнал
Subjects:	breast cancer androgen receptor androgen therapy anti-androgen therapy
Online Access:	https://www.siboncoj.ru/jour/article/view/1699

Similar Items

Editorial: The Androgen Receptor in Breast Cancer
by: Anna Tesei, et al.
Published: (2021-01-01)

Androgen Receptor Expression in Thai Breast Cancer Patients
by: Suthat Chottanapund, et al.
Published: (2016-09-01)

Current Status and Future Perspectives of Androgen Receptor Inhibition Therapy for Prostate Cancer: A Comprehensive Review
by: Tae Jin Kim, et al.
Published: (2021-03-01)

Androgen receptor expression as a prognostic and predictive marker in triple-negative breast cancer patients
by: Fatma Zakaria, et al.
Published: (2016-06-01)

Androgen receptor in relation to progesterone receptor (AR/PR ratio) in non-metastatic hormonal positive, Her2neu negative breast cancer
by: Maged A.F. Amine, et al.
Published: (2024-01-01)

The local hormonal environment of tumor and perifocal zone in patients with breast cancer: data and prospects of their application
by: Yu. S. Shatova, et al.
Published: (2016-11-01)

Androgen receptor function and targeted therapeutics across breast cancer subtypes
by: Emily A. Kolyvas, et al.
Published: (2022-11-01)

The Role of Androgens and Androgen Receptor in Human Bladder Cancer
by: Elizabeth Martínez-Rojo, et al.
Published: (2021-04-01)

Androgen receptor inhibitors in treating prostate cancer
by: Ryan N Cole, et al.
Published: (2025-03-01)

Lacrimal sac adenocarcinoma managed with androgen deprivation
by: David H. Abramson, et al.
Published: (2020-09-01)

Androgen Receptor Roles in Benign and Malignant Prostate Disease
Published: (2011-06-01)

A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma – the DUCT study protocol
by: Jetty A. M. Weijers, et al.
Published: (2024-09-01)

Androgen Receptor as an Emerging Feasible Biomarker for Breast Cancer
by: Chan-Ping You, et al.
Published: (2022-01-01)

Androgen receptors and serum testosterone levels identify different subsets of postmenopausal breast cancers
by: Secreto Giorgio, et al.
Published: (2012-12-01)

Androgen Receptor in Breast Cancer—Clinical and Preclinical Research Insights
by: Aristomenis Anestis, et al.
Published: (2020-01-01)

Prostate cancer and therapeutic challenges
by: Yousef MohammedRabaa Hawsawi, et al.
Published: (2020-12-01)

Systemic therapy of androgenic alopecia
by: I. N. Kondrakhina, et al.
Published: (2017-08-01)

Androgen receptor gene mutations in 46, XY females
by: Mir Davood Omrani, et al.
Published: (2006-12-01)

Androgens and Androgen Receptor Actions on Bone Health and Disease: From Androgen Deficiency to Androgen Therapy
by: Jia-Feng Chen, et al.
Published: (2019-10-01)

Androgen receptor targeted therapies in metastatic castration-resistant prostate cancer – The urologists' perspective
by: Jo-Lynn Tan, et al.
Published: (2017-12-01)

New advances of the androgen receptor in prostate cancer: report from the 1st International Androgen Receptor Symposium
by: Sherif Mehralivand, et al.
Published: (2024-01-01)

How do we define “castration” in men on androgen deprivation therapy?
by: Sarin Itty, et al.
Published: (2020-01-01)

The role of 11-oxygenated androgens in prostate cancer
by: Gido Snaterse, et al.
Published: (2023-04-01)

Partial Androgen Insensitivity Syndrome Presenting with Gynecomastia
by: Sung Won Lee, et al.
Published: (2015-06-01)

Influence of endocrine therapy on the ratio of androgen receptor (AR) to estrogen receptor (ER) positive circulating epithelial tumor cells (CETCs) in breast cancer
by: Monika Pizon, et al.
Published: (2018-12-01)

Incidence, Management, and Prevention of Gynecomastia and Breast Pain in Patients with Prostate Cancer Undergoing Antiandrogen Therapy: A Systematic Review and Meta-analysis of Randomized Controlled Trials
by: Ichiro Tsuboi, et al.
Published: (2025-03-01)

Androgens in Patients With Luminal B and HER2 Breast Cancer Might Be a Biomarker Promoting Anti-PD-1 Efficacy
by: Peng Li, et al.
Published: (2022-06-01)

Metastatic cutaneous apocrine adenocarcinoma successfully treated with systemic anti‐androgen therapy—A case report
by: Fanny Collette, et al.
Published: (2020-12-01)

Research Progress of Androgen/Androgen Receptor Signaling Pathway in Hepatocellular Carcinoma
by: WANG Ruihua, et al.
Published: (2023-02-01)

Androgen Signaling in Uterine Diseases: New Insights and New Targets
by: Mu Lv, et al.
Published: (2022-11-01)

Androgen and Androgen Receptors as Regulators of Monocyte and Macrophage Biology in the Healthy and Diseased Lung
by: Mireya Becerra-Diaz, et al.
Published: (2020-08-01)

Sequential Androgen Receptor Pathway Inhibitor in Prostate Cancer: Piling-Up The Benefits or a Case for Cross-Resistance?
by: Bertrand Tombal
Published: (2014-11-01)

Increased AR expression in castration-resistant prostate cancer rapidly induces AR signaling reprogramming with the collaboration of EZH2
by: Maryam Labaf, et al.
Published: (2022-11-01)

The clock gene BHLHE40 and atypical CCNG2 control androgen-induced cellular senescence as a novel tumor suppressive pathway in prostate cancer
by: Mehdi Heidari Horestani, et al.
Published: (2024-06-01)

First Line Androgen Deprivation Therapy vs. Chemotherapy for Patients With Androgen Receptor Positive Recurrent or Metastatic Salivary Gland Carcinoma—A Retrospective Study
by: Paul V. Viscuse, et al.
Published: (2019-08-01)

Integrins and Actions of Androgen in Breast Cancer
by: Chung-Che Tsai, et al.
Published: (2023-08-01)

Androgens and severity of the new coronavirus infection course
by: A. A. Gritskevich, et al.
Published: (2022-06-01)

Genomic Deletion at 10q23 in Prostate Cancer: More Than PTEN Loss?
by: Raghavendra Tejo Karthik Poluri, et al.
Published: (2018-06-01)

Selective Androgen Receptor Modulators - A Review of Potential Uses, Benefits, Side effects and Limitations
by: Kamil Ostafin, et al.
Published: (2023-08-01)

Androgen receptor in advanced breast cancer: is it useful to predict the efficacy of anti-estrogen therapy?
by: Giuseppe Bronte, et al.
Published: (2018-03-01)